
Managing Adverse Events in Pembrolizumab Therapy for Gastric Cancer
Yelena Y. Janjigian, MD, Chief Attending Physician of the Gastrointestinal Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, discusses how oncologists should manage potential adverse events associated with pembrolizumab (Keytruda) …